Z5D-14835-62351
4 vaccinations
2 coded responses
39 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-14
Survey response — day 0, dose 2MedDRA: Discomfort, Feeling hot, Hypersensitivity, Immediate post-injection reaction, Medical counselling, Pruritus, Swelling face — Feeling: FairFree text: Slight allergic reaction: Mild itchiness all over body starting about 5 minutes after injection and then becoming more noticeable about 30min after injection. Persisted the rest of the day but remained mild. Also felt like face was a bit warm and swollen but was not visible in a mirror. No rash noted. Spoke to a nurse from (b)(6) (where I received my vaccine) and was told it was ok to take a bendaryl. Took half of a 25mg tablet. Slept for about 4 hours. Still feel lingering itchiness but is less uncomfortable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
- 2021-10-13
-
2021-11-08
Dose 3 — Moderna
- 2022-04-16
-
2022-08-09
Dose 4 — Moderna
- 2022-08-09
-
2022-08-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-18
- 2022-08-23
- 2022-08-30
- 2022-09-06
-
2022-09-20
Survey response — day 42, dose 4MedDRA: Exposure to SARS-CoV-2, Malaise, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had Covid symptoms 9/12-9/17 but tested negative via at home tests 4 times throughout that period. I had been in close contact with two other people who started experiencing symptoms at the same time as I did, but tested positive.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-08
- 2023-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-11-08 | Moderna | No |
| 4 | 2022-08-09 | Moderna | No |
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Slight allergic reaction: Mild itchiness all over body starting about 5 minutes after injection and then becoming more noticeable about 30min after injection. Persisted the rest of the day but remained mild. Also felt like face was a bit warm and swollen but was not visible in a mirror. No rash noted. Spoke to a nurse from (b)(6) (where I received my vaccine) and was told it was ok to take a bendaryl. Took half of a 25mg tablet. Slept for about 4 hours. Still feel lingering itchiness but is less uncomfortable.
redacted (b)(6)
Release 12 — day 42, dose 4
Symptoms: Had Covid symptoms 9/12-9/17 but tested negative via at home tests 4 times throughout that period. I had been in close contact with two other people who started experiencing symptoms at the same time as I did, but tested positive.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Discomfort | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Medical counselling | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release